Display options
Cite
Yu P, Li Y, Fu W, et al. . Front Pharmacol. 2021;11:607813doi: 10.3389/fphar.2020.607813.
Yu, P., Li, Y., Fu, W., Li, X., Liu, Y., Wang, Y., Yu, X., Xu, H., & Sui, D. (2020). . Frontiers in pharmacology, 11607813. https://doi.org/10.3389/fphar.2020.607813
Yu, Ping, et al. "." Frontiers in pharmacology vol. 11 (2020): 607813. doi: https://doi.org/10.3389/fphar.2020.607813
Yu P, Li Y, Fu W, Li X, Liu Y, Wang Y, Yu X, Xu H, Sui D. . Front Pharmacol. 2021 Jan 15;11:607813. doi: 10.3389/fphar.2020.607813. eCollection 2020. PMID: 33628178; PMCID: PMC7898550.
Copy Download .nbib Format: NLM
Share it on

Front Pharmacol. 2021 Jan 15;11:607813. doi: 10.3389/fphar.2020.607813. eCollection 2020.

[No title available]

Frontiers in pharmacology

Ping Yu, Yuangeng Li, Wenwen Fu, Xin Li, Yanzhe Liu, Yaozhen Wang, Xiaofeng Yu, Huali Xu, Dayun Sui

Affiliations

  1. Department of Pharmacology, School of Pharmaceutical Sciences, Jilin University, Changchun, China.

PMID: 33628178 PMCID: PMC7898550 DOI: 10.3389/fphar.2020.607813

Abstract

At present, many patients who undergo reperfusion immediately after percutaneous coronary intervention will undergo microvascular obstruction and reduction in myocardial blood flow. This phenomenon is called "no-reflow (NR)," and there is still no effective therapy for NR. Studies showed

Copyright © 2021 Yu, Li, Fu, Li, Liu, Wang, Yu, Xu and Sui.

Keywords: NLRP3 inflammasome; inflammatory response; leukocytes; myocardial ischemia reperfusion no-reflow; panax quinquefolius L. saponin

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. J Ethnopharmacol. 2020 Oct 28;261:113069 - PubMed
  2. Basic Res Cardiol. 2019 Dec 12;115(1):5 - PubMed
  3. Biosci Rep. 2020 Jul 31;40(7): - PubMed
  4. Am J Physiol. 1994 Apr;266(4 Pt 2):H1316-21 - PubMed
  5. J Mol Cell Cardiol. 2020 May;142:65-79 - PubMed
  6. Clin Res Cardiol. 2020 Oct;109(10):1282-1291 - PubMed
  7. Can J Physiol Pharmacol. 2016 Dec;94(12):1325-1335 - PubMed
  8. Angiogenesis. 2020 Aug;23(3):299-314 - PubMed
  9. Cell Physiol Biochem. 2018;49(2):798-815 - PubMed
  10. Eur Heart J Acute Cardiovasc Care. 2020 Mar;9(2):99-101 - PubMed
  11. Exp Ther Med. 2020 Mar;19(3):1655-1664 - PubMed
  12. Int J Mol Med. 2020 Aug;46(2):561-570 - PubMed
  13. Oxid Med Cell Longev. 2019 Sep 10;2019:8948657 - PubMed
  14. Antioxidants (Basel). 2019 Sep 01;8(9): - PubMed
  15. Basic Res Cardiol. 2020 May 25;115(4):39 - PubMed
  16. Maedica (Bucur). 2019 Dec;14(4):323-325 - PubMed
  17. Int J Mol Sci. 2017 Nov 03;18(11): - PubMed
  18. J Cardiovasc Pharmacol. 2019 Oct;74(4):271-275 - PubMed
  19. Pharmacol Res. 2020 Jun;156:104771 - PubMed
  20. Antioxidants (Basel). 2019 Nov 05;8(11): - PubMed
  21. Front Immunol. 2019 Jul 10;10:1592 - PubMed
  22. Int J Cardiol. 2019 Jan 1;274:27-34 - PubMed
  23. Basic Res Cardiol. 2019 Oct 15;114(6):45 - PubMed
  24. Sci Rep. 2016 Dec 21;6:39412 - PubMed
  25. Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6529-6537 - PubMed
  26. Basic Res Cardiol. 2020 Oct 14;115(6):63 - PubMed
  27. Int J Microcirc Clin Exp. 1995 Sep-Oct;15(5):265-70 - PubMed
  28. Mol Med Rep. 2020 Feb;21(2):641-648 - PubMed
  29. Biomed Pharmacother. 2017 Jul;91:1042-1052 - PubMed
  30. Life Sci. 2017 Oct 1;186:50-58 - PubMed
  31. Cell Death Dis. 2016 May 26;7:e2234 - PubMed
  32. Circ Res. 2017 Apr 28;120(9):1477-1486 - PubMed
  33. Elife. 2017 Nov 09;6: - PubMed
  34. J Cardiovasc Pharmacol. 2019 Apr;73(4):215-222 - PubMed
  35. Int Immunopharmacol. 2020 Aug;85:106680 - PubMed
  36. Eur J Pharmacol. 2016 Feb 5;772:115-23 - PubMed
  37. Trials. 2016 Aug 18;17:412 - PubMed
  38. Compr Physiol. 2016 Dec 6;7(1):113-170 - PubMed
  39. Cell Physiol Biochem. 2014;34(4):1413-26 - PubMed
  40. Nat Rev Immunol. 2004 Jun;4(6):469-78 - PubMed
  41. Am J Physiol. 1994 Oct;267(4 Pt 2):H1329-36 - PubMed
  42. J Cardiovasc Pharmacol. 2019 Sep;74(3):228-234 - PubMed
  43. Am J Med Sci. 2016 Sep;352(3):261-6 - PubMed
  44. Int Rev Cell Mol Biol. 2012;298:229-317 - PubMed

Publication Types